OCGN pumps on dismissal of investor lawsuit LONG

OCGN has been a great swing trade after buying bad news. The good news has replaced the

bad. Earnings are in three days. Price well below ATH. November earnings were a beat

meaning this risky Med Tech penny stock had a lower cash burn than projected. Now

legal costs will disappear. Going long with a decent position expecting a better earnings.

In law, the Latin phrase res ipsa loquitur is sometimes used. Here it aptly applies to

Ocugen.